Lipid lowering therapy in patients with HIV infection (multiple letters) [3]

Lancet

Volumn 352, Issue 9142, 1998, Pages 1782-1783

  Wierzbicki, A S ^a   Reynolds, T M ^a   Crook, M A ^a   Tatler, J ^a   Peters, B S ^a   McBride, M ^a   Chin, M T M ^a   Lee, S M ^a   Kelly, B ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; BEZAFIBRATE; CERIVASTATIN; CIPROFIBRATE; CYTOCHROME; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; GEMFIBROZIL; MEVINOLIN; RITONAVIR; SAQUINAVIR; SIMVASTATIN; STATIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LIPID; PROTEINASE INHIBITOR;

ARTERY DISEASE; ATHEROMA; DISEASE SEVERITY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; LETTER; LIVER DISEASE; LIVER FUNCTION TEST; MYALGIA; PANCREATITIS; PRIORITY JOURNAL; RELAPSE; BLOOD; CHEMICALLY INDUCED DISORDER; HALF LIFE TIME; METABOLIC CLEARANCE RATE; NOTE; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; DRUG COMBINATION; MALE; MIDDLE AGED; PANCREAS PSEUDOCYST; RISK FACTOR;

ANTI-HIV AGENTS; ANTILIPEMIC AGENTS; HALF-LIFE; HIV INFECTIONS; HUMANS; HYPERLIPIDEMIAS; LIVER FUNCTION TESTS; METABOLIC CLEARANCE RATE; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; HIV PROTEASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; PANCREATIC PSEUDOCYST; PANCREATITIS; RISK FACTORS; RITONAVIR; SAQUINAVIR;

EID: 0032576325     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)79858-5     Document Type: Letter

References (2)

1. K Henry H Melroe J Huebesch Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities Lancet 352 1998 1031 1032
2. JM Schapiro MA Winters F Stewart The effect of high dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients Ann Intern Med 124 1996 1039 1050